Related Experiment Video
Updated: Aug 6, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
High prevalence of hepatitis C virus genotype 6 among certain risk groups in Hong Kong
Insights
Hepatitis C virus (HCV) genotypes were analyzed in diverse patient groups. Genotype 1b predominated in chronic liver disease patients, while genotype 6 was prevalent in thalassaemia major and intravenous drug abusers, suggesting potential clonal spread.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Hepatitis C virus (HCV) infection is a global health concern.
- Understanding HCV genotype distribution is crucial for effective treatment and public health strategies.
- Chronic liver diseases, thalassaemia major, chronic renal failure (CRF), haemophilia, and intravenous drug abuse (IVDA) represent distinct risk groups for HCV infection.
Purpose of the Study:
- To determine the distribution of Hepatitis C virus (HCV) genotypes in various patient populations.
- To investigate potential differences in genotype prevalence across different risk groups.
Main Methods:
- Genotyping of 172 HCV-RNA positive serum specimens.
- Analysis of the amplified 5' untranslated region (5'UTR) of the HCV genome.
- Utilized genotype-specific oligonucleotide probes and restriction fragment length polymorphism (RFLP) for precise identification.
Main Results:
- Six distinct HCV genotypes and subtypes were identified: 1a, 1b, 2, 3, 4, and 6.
- Genotype 1b was predominant (69.6%) in patients with chronic liver diseases.
- Genotype 6 showed significant prevalence in thalassaemia major (50%) and IVDA (62.5%) groups.
- Patients with CRF exhibited a genotype distribution similar to those with chronic liver diseases.
- Haemophilia patients displayed the highest diversity of HCV genotypes, likely due to overseas-manufactured Factor VIII administration.
Conclusions:
- Significant variations in HCV genotype distribution exist among different risk groups.
- The high prevalence of genotype 6 in thalassaemia major and IVDA populations suggests potential localized transmission or clonal spread.
- Further investigation into the transmission dynamics of HCV genotype 6 within specific subsets of the Hong Kong population is warranted.
Abstract:
The genotype of hepatitis C virus (HCV) of 172 HCV-RNA positive serum specimens taken from patients with chronic liver diseases, thalassaemia major, chronic renal failure (CRF), haemophilia and intravenous drug abusers (IVDA) was determined by analysis of the amplified 5'UTR region by genotype-specific oligonucleotide probes and restriction fragment length polymorphism (RFLP). Six different genotypes and subtypes (1a, lb, 2, 3, 4 and 6) were found. Genotype lb was the predominant genotype among patients with chronic liver diseases (69.6%), followed by genotype 6 (18.8%), which was similar to that reported for blood donors in earlier studies. Pronounced differences in the distribution of genotypes were seen between the four risk groups. Patients with CRF had a similar distribution to those with chronic liver diseases, whilst the greatest diversity of genotypes was seen in patients with haemophilia, which was expected since they were given factor VIII manufactured overseas. Genotype 6 was particularly prominent in patients with thalassaemia major (50%) and IVDA (62.5%). It is possible that clonal spread of HCV genotype 6 has taken place among a closed subset of the population in Hong Kong through intravenous drug abuse.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Cytomegalovirus Disease
Hepatitis
Genital Herpes
Amebiasis
Viral Hepatitis I: Introduction

